The Pyrosequencing-Based Method for JAK2 Exon 12 Somatic Mutation Detection

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• JAK2 exon 12 mutations are key diagnostic markers for myeloproliferative neoplasms (MPN).
• These mutations are integral to the World Health Organization's diagnostic criteria for polycythemia vera (PV).
• Accurate detection is vital for differential diagnosis in MPN cases.

Purpose of the Study:

• To develop and validate a pyrosequencing technique for detecting somatic mutations in JAK2 exon 12.
• To assess the qualitative and quantitative performance of this pyrosequencing method.
• To evaluate the method's utility in a cohort of polycythemia vera patients.

Main Methods:

• PCR and pyrosequencing primers were designed for the JAK2 exon 12 region.
• PCR conditions were optimized for pyrosequencing-based detection.
• Analytical sensitivity and specificity were determined using plasmid controls, and the method was validated on 145 MPN patient DNA samples.

Main Results:

• The pyrosequencing method demonstrated analytical sensitivity with a limit of detection ranging from 3.4% to 9.9%.
• JAK2 exon 12 mutations were identified in 4.8% (7 of 145) of MPN patients.
• Complex mutations required Sanger sequencing confirmation, and allele burden changes were observed over time in one patient.

Conclusions:

• The developed pyrosequencing method offers a straightforward approach for detecting JAK2 exon 12 mutations.
• The technique provides both qualitative and quantitative analysis capabilities.
• Manual interpretation and Sanger confirmation may be necessary for certain complex JAK2 exon 12 mutation types.